STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features. We tell our stories from the places that matter to our readers — research labs, hospitals, executive suites, and political campaigns.
STAT+: Natural killer cells, primed with an antibody, induce remissions in patients with advanced blood cancer
Natural killer cells, primed with an antibody, induce remissions in patients ...Read more
STAT+: Pharmalittle: Regeneron antibody reduced Covid-19 infection risk; variant first seen in South Africa can somewhat ‘break through’ Pfizer shot
Regeneron Pharmaceuticals said a Phase 3 clinical trial of its Covid-19 antibody...Read more